Noticias de NVO_US

Noticias del mercado

Últimas noticias sobre NVO_US — 397 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: NVO_US ✕ 397 resultados
14/04/2026 NVO_US — Yahoo Finance ES ← EN
Novo Nordisk y OpenAI se asocian para transformar la forma en que se descubren y distribuyen los medicamentos
13/04/2026 NVO_US — Yahoo Finance
Novo Nordisk A/S - share repurchase programme
13/04/2026 NVO_US — Bloomberg
Novo Taps OpenAI to Speed Development of New Obesity Drugs
13/04/2026 NVO_US — Yahoo Finance UK
Novo Nordisk and OpenAI partner to transform how medicines are discovered and delivered
13/04/2026 NVO_US — Seeking Alpha
Novo Nordisk: Don't Stop Purchasing The Dip (NYSE:NVO)
13/04/2026 NVO_US — Yahoo Finance
Novo Nordisk A/S - share repurchase programme
13/04/2026 NVO_US — GlobeNewswire
Novo Nordisk A/S - share repurchase programme
12/04/2026 NVO_US — Yahoo Finance
How Novo Nordisk (NVO) Is Expanding Its Dominance in Obesity Care
10/04/2026 NVO_US — Yahoo Finance
Novo Nordisk A/S (NVO) Is a Trending Stock: Facts to Know Before Betting on It
10/04/2026 NVO_US — 24/7 Wall St.
Eli Lilly vs. Novo Nordisk: The Obesity Drug Race Has a New Leader
10/04/2026 NVO_US — CNBC
Eli Lilly market share drops, Novo Nordisk holds firm as generic weight-loss drugs flood India
10/04/2026 NVO_US — MarketScreener
Novo Nordisk A/S: A trend reversal can be anticipated
09/04/2026 NVO_US — Yahoo Finance
Novo Nordisk A/S: Wegovy® injection becomes first GLP-1 weight-loss treatment approved for 48-hour controlled-temperature delivery in the EU
09/04/2026 NVO_US — GlobeNewswire
Novo Nordisk A/S: Wegovy® injection becomes first GLP-1
07/04/2026 NVO_US — GlobeNewswire
Novo Nordisk A/S – Share repurchase programme
07/04/2026 NVO_US — Yahoo Finance
Novo Nordisk A/S – Share repurchase programme
07/04/2026 NVO_US — Yahoo Finance
Novo Nordisk A/S – Share repurchase programme
07/04/2026 NVO_US — GlobeNewswire
Novo Nordisk A/S – Share repurchase programme
06/04/2026 NVO_US — Seeking Alpha
Novo Nordisk: Downgrading To 'Sell' As GLP-1 Pipeline Faces Many Risks (NYSE:NVO)
03/04/2026 NVO_US — 24/7 Wall St.
Novo Nordisk Shares Down 43% in a Year as Generic Rivals Force 48% Price Cuts

Página 17 de 20

keyboard_arrow_up